Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy

This study is ongoing, but not recruiting participants.

Study NCT01160718 Information provided by Swiss Group for Clinical Cancer Research

First Received on July 9, 2010. Last Updated on November 1, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Breast Cancer

Additional conditions recognized in this trial

Breast Neoplasms

More general conditions related to this trial

Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases

Interventions listed in this trial

fulvestrant
selumetinib

Additional drug interventions recognized in this trial

Aromatase Inhibitors
Estradiol

More general drug interventions related to this trial

Sponsors listed in this trial